Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
15.78
+0.03 (0.19%)
Jan 2, 2026, 4:00 PM EST - Market closed
Prenetics Global Market Cap
Prenetics Global has a market cap or net worth of $265.55 million as of January 5, 2026. Its market cap has increased by 322.88% in one year.
Market Cap
265.55M
Enterprise Value
236.51M
1-Year Change
322.88%
Ranking
Category
Stock Price
$15.78
Market Cap Chart
Since September 30, 2021, Prenetics Global's market cap has decreased from $1.68B to $265.55M, a decrease of -84.17%. That is a compound annual growth rate of -35.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 265.55M | 0.19% |
| Dec 31, 2025 | 265.05M | 274.04% |
| Dec 31, 2024 | 70.86M | -0.24% |
| Dec 29, 2023 | 71.03M | -68.00% |
| Dec 30, 2022 | 221.96M | -86.75% |
| Dec 31, 2021 | 1.68B | -0.10% |
| Sep 30, 2021 | 1.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |